{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:57:51Z","timestamp":1787025471650,"version":"build-2736575974"},"reference-count":24,"publisher":"Society of Nuclear Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Nucl. Med.\n                Technol."],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.2967\/jnmt.116.185777","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T20:10:27Z","timestamp":1486066227000},"page":"34-41","source":"Crossref","is-referenced-by-count":31,"title":["MIB-1 Index\u2013Stratified Assessment of Dual-Tracer PET\/CT with\n                    <sup>68<\/sup>\n                    Ga-DOTATATE and\n                    <sup>18<\/sup>\n                    F-FDG and Multimodality Anatomic Imaging in Metastatic Neuroendocrine Tumors of Unknown Primary in a PRRT Workup Setting"],"prefix":"10.2967","volume":"45","author":[{"given":"Nikita","family":"Sampathirao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandip","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2017,2,2]]},"reference":[{"key":"2021051712223245000_45.1.34.1","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-006-0250-1"},{"key":"2021051712223245000_45.1.34.2","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-013-1410-8"},{"key":"2021051712223245000_45.1.34.3","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23469"},{"key":"2021051712223245000_45.1.34.4","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2805-8"},{"key":"2021051712223245000_45.1.34.5","doi-asserted-by":"publisher","DOI":"10.1159\/000368609"},{"key":"2021051712223245000_45.1.34.6","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/MNM.0000000000000321","article-title":"Correlation and discordance of tumour proliferation index and molecular imaging characteristics and their implications for treatment decisions and outcome pertaining to peptide receptor radionuclide therapy in patients with advanced neuroendocrine tumour: developing a personalized model","volume":"36","author":"Basu","year":"2015","journal-title":"Nucl Med Commun."},{"key":"2021051712223245000_45.1.34.7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cpet.2016.02.004","article-title":"PET-based molecular imaging in designing personalized management strategy in gastroenteropancreatic neuroendocrine tumors","volume":"11","author":"Basu","year":"2016","journal-title":"PET Clin."},{"key":"2021051712223245000_45.1.34.8","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-010-1512-3"},{"key":"2021051712223245000_45.1.34.9","first-page":"426","article-title":"The value of 68Ga-DOTATATE PET\/CT in diagnosis and management of neuroendocrine tumors compared to current FDA approved imaging modalities: a review of literature","volume":"4","author":"Mojtahedi","year":"2014","journal-title":"Am J Nucl Med Mol Imaging."},{"key":"2021051712223245000_45.1.34.10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.166017"},{"key":"2021051712223245000_45.1.34.11","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-008-0944-5"},{"key":"2021051712223245000_45.1.34.12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.106.035667"},{"key":"2021051712223245000_45.1.34.13","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-012-2330-6"},{"key":"2021051712223245000_45.1.34.14","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1097\/MNM.0000000000000547","article-title":"Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics","volume":"37","author":"Thapa","year":"2016","journal-title":"Nucl Med Commun."},{"key":"2021051712223245000_45.1.34.15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.0987"},{"key":"2021051712223245000_45.1.34.16","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-009-1205-y"},{"key":"2021051712223245000_45.1.34.17","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0b013e31823ea730"},{"key":"2021051712223245000_45.1.34.18","doi-asserted-by":"crossref","unstructured":"Kazmierczak PM Rominger A Wenter V . The added value of 68Ga-DOTA-TATE-PET to contrast-enhanced CT for primary site detection in CUP of neuroendocrine origin. Eur Radiol. July 19, 2016 [Epub ahead of print].","DOI":"10.1007\/s00330-016-4475-3"},{"key":"2021051712223245000_45.1.34.19","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s13139-013-0258-9","article-title":"Diagnostic value of 68Ga-DOTATATE PET\/CT in liver metastases of neuroendocrine tumours of unknown origin","volume":"48","author":"Tan","year":"2014","journal-title":"Nucl Med Mol Imaging."},{"key":"2021051712223245000_45.1.34.20","doi-asserted-by":"publisher","DOI":"10.1007\/s12149-012-0634-z"},{"key":"2021051712223245000_45.1.34.21","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-16-0099"},{"key":"2021051712223245000_45.1.34.22","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2015.1922"},{"key":"2021051712223245000_45.1.34.23","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1007\/s00259-016-3497-z","article-title":"The case for combined chemotherapy-peptide receptor radionuclide therapy (chemo-PRRT) strategy in metastatic neuroendocrine tumor: predicting and looking at the possible case scenarios","volume":"43","author":"Basu","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712223245000_45.1.34.24","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1097\/MEG.0000000000000619","article-title":"Evaluation of the concordance between the stage of the disease and Ki-67 proliferation index in gastroenteropancreatic neuroendocrine tumors","volume":"28","author":"\u00d6zaslan","year":"2016","journal-title":"Eur J Gastroenterol Hepatol."}],"container-title":["Journal of Nuclear Medicine Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnmt.116.185777","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T16:57:25Z","timestamp":1621270645000},"score":1,"resource":{"primary":{"URL":"http:\/\/tech.snmjournals.org\/lookup\/doi\/10.2967\/jnmt.116.185777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,2]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,3,21]]},"published-print":{"date-parts":[[2017,3]]}},"alternative-id":["10.2967\/jnmt.116.185777"],"URL":"https:\/\/doi.org\/10.2967\/jnmt.116.185777","relation":{},"ISSN":["0091-4916","1535-5675"],"issn-type":[{"value":"0091-4916","type":"print"},{"value":"1535-5675","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,2]]}}}